Literature DB >> 12215220

Redox-linked signal transduction pathways for protein tyrosine kinase activation.

Izumi Nakashima1, Masashi Kato, Anwarul A Akhand, Haruhiko Suzuki, Kozue Takeda, Kahled Hossain, Yoshiyuki Kawamoto.   

Abstract

The signaling for activation of protein tyrosine kinases (PTKs) is usually started by binding of ligands to cell-surface receptors. However, recent evidence suggests the presence of ligand binding-independent signaling pathways that are mediated by oxidative stress. Oxidation and reduction of protein cysteine sulfhydryl (SH) groups may work as a molecular switch to start or to stop the signaling. It is known that oxidation of cysteine SH groups on protein tyrosine phosphatases switches off the action of protein tyrosine phosphatases. This event may not, however, signal for initial autophosphorylation of previously unphosphorylated PTKs, whereas it certainly prevents dephosphorylation of once-phosphorylated PTKs. We have suggested new mechanisms for oxidative stress-mediated PTK activation. First, cell-surface glycosylphosphatidylinositol-anchoring proteins and a phosphoglycolipid/cholesterol-enriched membrane microdomain termed a "raft" can be the direct targets of oxidative stress for inducing their clustering through an S-S-bonded or S-X-S-bonded crosslinking of cell-surface proteins and subsequent activation of raft-associating Src family PTKs. Second, intracellular specific cysteine SH groups on PTK proteins can be another target of oxidative stress for inducing a conformational change necessary for initial activation of PTKs. A possible relationship between cell-surface and intracellular events is that the former frequently induces superoxide production as the second messenger for the latter.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12215220     DOI: 10.1089/15230860260196326

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  27 in total

Review 1.  Angiogenic signal during cardiac repair.

Authors:  Nilanjana Maulik
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

Review 2.  Crosstalk of reactive oxygen species and NF-κB signaling.

Authors:  Michael J Morgan; Zheng-gang Liu
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

Review 3.  TRPC channels and their implication in neurological diseases.

Authors:  Senthil Selvaraj; Yuyang Sun; Brij B Singh
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

Review 4.  ROS signaling and redox biology in endothelial cells.

Authors:  Emiliano Panieri; Massimo M Santoro
Journal:  Cell Mol Life Sci       Date:  2015-05-14       Impact factor: 9.261

Review 5.  Redox signaling at invasive microdomains in cancer cells.

Authors:  Begoña Díaz; Sara A Courtneidge
Journal:  Free Radic Biol Med       Date:  2011-09-29       Impact factor: 7.376

Review 6.  Signaling components of redox active endosomes: the redoxosomes.

Authors:  Fredrick D Oakley; Duane Abbott; Qiang Li; John F Engelhardt
Journal:  Antioxid Redox Signal       Date:  2009-06       Impact factor: 8.401

Review 7.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

8.  c-Src-mediated phosphorylation of NoxA1 and Tks4 induces the reactive oxygen species (ROS)-dependent formation of functional invadopodia in human colon cancer cells.

Authors:  Davide Gianni; Nicolas Taulet; Céline DerMardirossian; Gary M Bokoch
Journal:  Mol Biol Cell       Date:  2010-10-13       Impact factor: 4.138

Review 9.  Emerging evidence for the importance of phosphorylation in the regulation of NADPH oxidases.

Authors:  Gary M Bokoch; Becky Diebold; Jun-Sub Kim; Davide Gianni
Journal:  Antioxid Redox Signal       Date:  2009-10       Impact factor: 8.401

10.  Hydrogen peroxide-induced Akt phosphorylation regulates Bax activation.

Authors:  Mahdieh Sadidi; Stephen I Lentz; Eva L Feldman
Journal:  Biochimie       Date:  2009-02-06       Impact factor: 4.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.